Company Performance Metrics
AssureDrop develops biotechnology research tools focused on droplet microfluidics-based screening of critical biological samples. The company offers a pipette-free droplet screening platform that operates directly within standard multiwell plates to handle sub-microlitre droplets. Its technology supports high-throughput screening of organoids,
tumor spheroids, and stem cell models across formats including 1536-well plates. The platform is designed to optimize use of scarce patient-derived samples by enabling more assay conditions from limited material. It integrates into existing laboratory workflows and 3D cell culture processes used in oncology research, genetic analysis, and targeted therapeutic development. AssureDrop’s system also aims to reduce consumable use and operational costs by minimizing plastic waste and replicates in screening workflows.
